Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 21, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on...
Month: May 2021
Core One Labs Provides Clarification on Trading Activity
VANCOUVER, BC / ACCESSWIRE / May 21, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the "Company" or "Core...
MorphoSys To Participate in UBS Global Healthcare Conference
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 21, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that Jean-Paul Kress, M.D., the company's...
SANUWAVE Health and JV Partner Diversa S.A. Announce Distribution Agreement with Grupo Suprimed
SUWANEE, GA / ACCESSWIRE / May 21, 2021 / SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation wound care...
AG Mednet Names Michael Svinte Chief Commercial Officer, Will Grow Commercial Team Globally
BOSTON, MA / ACCESSWIRE / May 21, 2021 / AG Mednet, a technology company with a mission to speed medical...
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company...
Université de Sherbrooke and deutraMed, a KEY DH Technologies’ Subsidiary, Accelerate $500,000 mRNA Vaccine Stabilization Technology Project
Collaboration Seeks To Alleviate Cold Storage Requirements for mRNA COVID Vaccines, Enhance Other Medical Therapeutics SHERBROOKE, QC and COLLINGWOOD, ON...
Correction: Coloplast A/S – Trading in Coloplast shares by board members, executives or associated persons
Please see enclosed pdf. The transaction concerns purchase of shares. Attachment 2105021_trading_in_shares_GL_corrected
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency
European Commission decision anticipated in JulyBOSTON, May 21, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical...
Albireo Receives Positive CHMP Opinion for Bylvay™ (odevixibat) for Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)
– Bylvay has the potential to become first approved drug to treat all forms of PFIC – – CHMP opinion...
Zymergen to Present at UBS Global Healthcare Virtual Conference
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming...
Myovant Sciences Receives Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Treatment of Women With Uterine Fibroids
CHMP opinion recommending approval based on data from the Phase 3 LIBERTY program in women with uterine fibroidsGedeon Richter will...
Share issue / transfer and annulment of shares in connection with reduction of the quantity of shares in Nexstim Plc
Company announcement, Helsinki, 21 May 2021 at 3:30 PM (EEST) Share issue / transfer and annulment of shares in connection...
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Brings Best-in-Class Team to Psychedelics Development
NEW YORK, May 21, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of...
ProMIS Neurosciences re-initiates path to IND for PMN310 with producer cell line development
PMN310 potential best in class antibody candidate for treatment of Alzheimer’s diseaseTORONTO and CAMBRIDGE, Mass., May 21, 2021 (GLOBE NEWSWIRE)...
InspireMD Commences Trading on Nasdaq-CM
Ticker to remain NSPRTEL AVIV, Israel, May 21, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq-CM: NSPR), developer of the CGuard™...
EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
– Opinion based on the EMA’s Committee for Human Medicinal Products (CHMP) review of available data on sotrovimab (previously VIR-7831)...
Onconova Therapeutics Announces the Initial Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of ON 123300
Phase 1 study to evaluate ON 123300 in advanced cancer patients including HR+ HER 2- metastatic breast cancer patients resistant...
Cullinan Oncology Announces Management Transition
CAMBRIDGE, Mass., May 21, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), an oncology company seeking to drive...
XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) recently learned its licensees are presenting at the...